“The biological seed treatment market is projected to grow at a CAGR of 11.10%.”
The biological seed treatment market is projected to reach USD 1,251.4 million by 2022, from USD 739.3 million in 2017, at a CAGR of 11.10%. The global biological seed treatment market is driven by factors such as providing an insurance to better crop yields, along with a reduction in the risk of exceeding the Maximum Residue Levels (MRLs). Low level of awareness about the benefits of biological seed treatment among farmers across the globe is a major restraint in this market.
“Corn segment led the market with the largest share in 2016.”
The demand for biological seed treatment in corn has been witnessing substantial growth in the European and American regions, due to the significant requirement of corn as animal protein and ethanol in the feed and automobile industries, respectively. Thus, the corn segment accounted for the major share in the biological seed treatment market.
“Microbials segment is projected to be the fastest-growing from 2017 to 2022.”
Microbial seed treatment includes bacterial and fungal seed treatment. Seeds treatment provides an efficient mechanism for the placement of microbial inoculum in the soil environment, where they are appropriately positioned to colonize the seedling & roots and protect them against soil-borne diseases and pests. Thus, the microbials segment is projected to grow at the highest rate during the forecast period.
“North America led the market with the largest share in 2016.”
North America was the largest biological seed treatment market in 2016. The streamlined guidelines, procedures, and effective feedback adopted by North American agrochemical regulatory agencies have been supportive of the product registration process as compared to Europe. North America was followed by the European market in 2016 which has also witnessed a strong adoption trend of these products.
The breakdown of the primaries on the basis of company, designation, and region conducted during the research study, is as follows:
- By Company type: Tier 1 – 50%, Tier 2 –30%, and Tier 3 – 20%
- By Designation: C-Level – 20%, D-Level – 35%, Others* – 45%
- By Region: North America – 37%, Europe – 25%, Asia Pacific – 28%, South America -10%
*Others include sales managers, marketing managers, and product managers.
Note: Tier 1: Revenue >= USD 1 billion; Tier 2: USD 100 million to USD 1 billion; Tier 3: Revenue =< USD 100 million
The global market for biological seed treatment is dominated by large players such as BASF (Germany), Bayer (Germany), Syngenta (Switzerland), Monsanto (US), and DuPont (US). Some emerging players in the biological seed treatment market include Valent BioSciences (US), Verdesian Life Sciences (US), Plant Health Care (US), Precision Laboratories (US), Koppert (Netherlands), Italpollina (Italy), and Incotec (Netherlands).
The report analyzes the biological seed treatment market across different types and regions. It aims at estimating the market size and future growth potential of this market across different segments such as type, crop, function, and region. Furthermore, the report also includes in-depth competitive analysis of the key players in the market along with their company profiles, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help the market leaders/new entrants in this market by providing them the closest approximations of the revenue numbers for the overall biological seed treatment market and its subsegments. This report will help stakeholders to better understand the competitor landscape, gain more insights to better position their businesses, and devise suitable go-to-market strategies. The report will also help stakeholders to understand the market and provide them information on key market drivers, restraints, challenges, and opportunities.